Skip to content
Screener

Climb Bio, Inc. CLYM Other Non-Current Assets

Other Non-Current Assets at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$6.38B+7.4%
Amgen logo
AmgenAMGN
$12.98B+17.7%
Vera Therapeutics logo
Vera TherapeuticsVERA
$5.94M+494%
Kyverna Therapeutics, Inc. logo
Kyverna Therapeutics, Inc.KYTX
$5.01M+37.6%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$297K-19.1%
Artiva Biotherapeutics, Inc. logo
Artiva Biotherapeutics, Inc.ARTV
$809K+2,029%

Other financials

Income statement

See full
Operating income-$15.2M+33.9%
Net income-$13.7M+34.0%
EPS (diluted)-$0.20+35.5%

Balance sheet

See full
Cash & equivalents$8.4M-71.2%
Total debt$479.0K+1.1%
Total equity$148.1M-23.4%
Total assets$152.4M-24.1%

Cash flow

See full
Operating cash flow-$14.4M+6.8%
CapEx$109.0K
Free cash flow-$15.6M-183%

Valuation

See full
Market cap$777.69M+597%
Enterprise value$769.81M+761%

Returns & leverage

See full
Return on equity-30.9%-10.3pp
Debt / equity0.0×
Current ratio27.9×+13.6×

Where this comes from

Reported directly by Climb Bio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The source filing: Climb Bio, Inc.’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 7:30 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-210357
Line itemMarch 31, 2026December 31, 2025
Long-term marketable securities36,74159,572
Operating lease right-of-use assets447505
Property and equipment, net250288
Other long-term assets1,5301,530
Total assets$152,372$167,744
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable$860$2,269

Item 1. Condensed Consolidated Financial Statements (unaudited)

FAQ

What is Climb Bio, Inc.'s other non-current assets?
Climb Bio, Inc. (CLYM) reported other non-current assets of $1.53M in Q1 2026.
How has Climb Bio, Inc.'s other non-current assets changed year-over-year?
Climb Bio, Inc.'s other non-current assets increased by 577.0% year-over-year, from $226K to $1.53M.
What is the long-term trend for Climb Bio, Inc.'s other non-current assets?
Over 5 years (2020 to 2025), Climb Bio, Inc.'s other non-current assets has grown at a -10.3% compound annual growth rate (CAGR), from $2.63M to $1.53M.
What does other non-current assets mean?
Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.

Ask your AI about Climb Bio, Inc.'s other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude